All Stories

  1. Transfusion-associated graftversus- host disease: A brief comment on blood safety
  2. Transfusion-associated graft-versus-host disease: A concise review
  3. Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor
  4. Deferasirox in a refractory anemia after other treatment options: case report and literature review
  5. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients